Volumetric parameters from [ <scp> <sup>18</sup> F </scp> ] <scp>FDG PET</scp> / <scp>CT</scp> predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms-Reference-Cited by-同舟云学术

Volumetric parameters from [ ¹⁸ F ] FDG PET / CT predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms

Published:2022-06-21 Issue:7 Volume:34 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinology

Author:

Langen Stokmo Henning¹²^ORCID,Aly Mahmoud³⁴,Bowitz Lothe Inger Marie⁵,Borja Austin J.³⁶,Mehdizadeh Seraj Siavash³,Ghorpade Rina³,Miao Xuan³,Hjortland Geir Olav⁷,Malinen Eirik⁸⁹,Sorbye Halfdan¹⁰¹¹,Werner Thomas J.³,Alavi Abass³,Revheim Mona‐Elisabeth¹²³

Affiliation:

1. Division of Radiology and Nuclear Medicine Oslo University Hospital Oslo Norway

2. Institute of Clinical Medicine, Faculty of Medicine University of Oslo Oslo Norway

3. Department of Radiology Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

4. Department of Radiology Asyut University Hospital Asyut Egypt

5. Department of Pathology Oslo University Hospital Oslo Norway

6. Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

7. Department of Oncology Oslo University Hospital Oslo Norway

8. Department of Medical Physics Oslo University Hospital Oslo Norway

9. Department of Physics University of Oslo Oslo Norway

10. Department of Oncology Haukeland University Hospital Bergen Norway

11. Department of Clinical Science University of Bergen Bergen Norway

Funder

Helse Sør-Øst RHF

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jne.13170

Reference63 articles.

1. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

2. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases

3. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging;Pharmaceuticals;2024-03-14

2. Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas;Molecular Imaging and Biology;2024-02-08

3. Novel ensemble feature selection techniques applied to high-grade gastroenteropancreatic neuroendocrine neoplasms for the prediction of survival;Computer Methods and Programs in Biomedicine;2024-02

4. [¹⁸F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study;Journal of Nuclear Medicine;2023-12-21

5. Dual 68Ga -DOTANOC and 18F -FDG PET/CT in metastatic gastrointestinal neuroendocrine neoplasms with or without surgical resection of the primary site;2023-10-03